$20.060
-0.676 (-3.37%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
NAMS 相似图表分析预测
Alphio's NAMS stock price prediction model matches the current NewAmsterdam Pharma Company NV tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $20.12 (+0.32%). The 1-week path is $21.10 (+5.20%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 NewAmsterdam Pharma Company NV 股票吗？
NewAmsterdam Pharma is not a good buy right now due to its significant financial losses and negative market sentiment. The current price is $19.71, but the company reported a widening net loss of $64.1 million in Q2, which is a substantial increase from a $17.4 million loss in the same period last year. Additionally, the RSI is at 31.606, indicating that the stock is oversold, but this does not outweigh the risks associated with its declining revenue and high insider selling activity, which has increased by 113.69% over the last month. The forward P/E ratio is 119.05, indicating that the stock is overvalued compared to its earnings potential, and the recent analyst downgrade reflects caution regarding the company's future performance.
NAMS 股价于 Friday 收于 $20.06，此前下跌 -3.37%
NewAmsterdam Pharma Company NV (NAMS) last closed at $20.0599995, losing -3.37%. These facts feed the 1-day and 1-week NAMS price prediction above.
预测驱动因素
NewAmsterdam Pharma Company NV（NAMS）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
相似图表形态
近期走势与 NAMS 最接近的股票，按相似度排序。
NAMS 季节性分析
Historically the probability of a positive October return for NAMS is 67.65%. November offers the highest probability of a positive month at 100.00%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
NAMS 十年价格预测
| 月份 | 最低价 | 平均价 | 最高价 | 潜在回报率 |
|---|---|---|---|---|
| Oct 2026 | $24.81 | $32.88 | $41.42 | +63.89% |
| Nov 2026 | $33.96 | $41.82 | $49.82 | +108.47% |
| Dec 2026 | $33.82 | $41.16 | $42.47 | +105.17% |
2026 年，NewAmsterdam Pharma Company NV（NAMS）预计区间为 $24.81 至 $49.82。
NewAmsterdam Pharma Company NV 2026 年月度预测
2026 年 Oct，NewAmsterdam Pharma Company NV 预计均价 $32.88，最低 $24.81，最高 $41.42。
2026 年 Nov，NewAmsterdam Pharma Company NV 预计均价 $41.82，最低 $33.96，最高 $49.82。
2026 年 Dec，NewAmsterdam Pharma Company NV 预计均价 $41.16，最低 $33.82，最高 $42.47。
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。